In a move to address high drug prices in the United States, President Donald Trump has sent letters to 17 of the world's largest pharmaceutical companies, demanding they lower the prices of new medicines in the US to match the prices charged in other countries. The President's actions represent an escalation of his ongoing campaign to pressure the drug industry to reduce costs for American consumers. Trump has criticized the industry for charging significantly higher prices in the US compared to other nations, and this latest move is seen as an attempt to force the companies to align their US pricing with international standards. The pharmaceutical industry has faced growing scrutiny over its pricing practices, with concerns that high drug costs are making crucial medications unaffordable for many Americans. Trump's demand for price reductions is viewed as a direct challenge to the industry's business model and could have significant implications for the future of drug pricing in the United States.
Jul 31, 2025 → Aug 14, 2025
Eli Lilly, a US pharmaceutical company, is increasing the UK price of its weight loss medication Mounjaro by up to 170%. This comes after former US President Donald Trump put pressure on the pharmaceutical industry to make drugs more…
Read original at The Guardian →3 updates from 3 sources over 2 weeks.
Eli Lilly, a US pharmaceutical company, is increasing the UK price of its weight loss medication Mounjaro by up to 170%. This comes after former US President Donald Trump put pressure on the pharmaceutical industry to…
Read original at The Guardian →In a move to lower drug prices, the Trump administration has demanded that pharmaceutical companies reduce some of their U.S. prices by September. However, the administration has not provided a clear legal basis to…
Read original at NYT →In a move to address high drug prices in the United States, President Donald Trump has sent letters to 17 of the world's largest pharmaceutical companies, demanding they lower the prices of new medicines in the US to…
Read original at Bloomberg →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
Eli Lilly, a US pharmaceutical company, is increasing the UK price of its weight loss medication Mounjaro by up to 170%. This comes after former US President Donald Trump put pressure on the pharmaceutical industry to make drugs more…
View source →In a move to lower drug prices, the Trump administration has demanded that pharmaceutical companies reduce some of their U.S. prices by September. However, the administration has not provided a clear legal basis to enforce this demand.…
View source →In a move to address high drug prices in the United States, President Donald Trump has sent letters to 17 of the world's largest pharmaceutical companies, demanding they lower the prices of new medicines in the US to match the prices…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Long-running fight over Trump-backed maps takes another turn as absentee voting is already under way in Missouri. This blog is now closed. Sign up for US Breaking News emails Xi…
This new task force is Trump's latest response to the debate over AI safety.
The Trump administration’s decision to revoke the visa of a Peruvian judge who sided with a Chinese company in a port dispute puts a new spotlight on the growing US-China rivalry…
As Bosnians vote in an election this weekend, the country is embracing the US president’s family and friends.
On Equity, we discussed the Trump administration's attempts to rebrand AI.
Donald Trump and Xi Jinping discuss Taiwan arms sales every time they get together but the American stance on the self-ruled island remains unchanged following the Chinese…
